Monolith Management Ltd Acquires Shares of 133,665 Zepp Health Corporation Sponsored ADR $ZEPP

Monolith Management Ltd acquired a new stake in Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 133,665 shares of the company’s stock, valued at approximately $3,601,000. Zepp Health accounts for about 1.3% of Monolith Management Ltd’s holdings, making the stock its 15th largest position.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Public Employees Retirement System of Ohio acquired a new position in shares of Zepp Health in the third quarter valued at $43,000. Harvest Fund Management Co. Ltd increased its holdings in shares of Zepp Health by 6.7% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock valued at $1,207,000 after purchasing an additional 2,800 shares during the last quarter. Oasis Management Co Ltd. acquired a new position in shares of Zepp Health in the third quarter valued at $276,000. Dimensional Fund Advisors LP acquired a new position in shares of Zepp Health in the fourth quarter valued at $241,000. Finally, Capstone Capital Management Ltd acquired a new position in shares of Zepp Health in the fourth quarter valued at $298,000. 52.61% of the stock is currently owned by institutional investors and hedge funds.

Zepp Health Trading Up 2.0%

ZEPP stock opened at $5.14 on Wednesday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.67 and a current ratio of 0.88. The company’s 50-day simple moving average is $11.10 and its 200 day simple moving average is $18.46. Zepp Health Corporation Sponsored ADR has a 52 week low of $2.25 and a 52 week high of $61.85. The company has a market capitalization of $75.46 million, a PE ratio of -2.04 and a beta of 1.78.

Analyst Upgrades and Downgrades

Separately, Fundamental Research set a $56.28 price objective on shares of Zepp Health and gave the company a “buy” rating in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $56.28.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.